Closed
24.22 -2.34
24h
Min
23.8
Max
24.43
Income | 28M -13M |
---|---|
Sales | 33M 114M |
Profit margin | -11.145 |
Employees | 385 |
EBITDA | 13M -13M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +40.26% upside |
Next Earnings | 30 Oct 2025 |
---|
Market Cap | 838M 2.3B |
---|---|
Previous open | 26.56 |
Previous close | 24.22 |
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 34.77 USD 40.26%
High 47 USD
Low 25 USD
Based on 16 Wall Street analysts offering 12 month price targets forTravere Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$